Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$680M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
UnitedHealth
UNH
|
+$393M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$381M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.24B |
| 2 |
Tesla
TSLA
|
+$450M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$444M |
| 4 |
TSMC
TSM
|
+$432M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.79% |
| 2 | Consumer Discretionary | 0.82% |
| 3 | Financials | 0.79% |
| 4 | Healthcare | 0.66% |
| 5 | Industrials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12026
CALL
AerSale
ASLE
$273M
| $64.3K | ﹤0.01% |
10,700
-5,700
| -35% | -$36.5K |
|
12027
PUT
ARKO Corp
ARKO
$524M
| $64.3K | ﹤0.01% |
15,200
-19,200
| -56% | -$83.9K |
|
12028
NLI Holdings
NL
$322M
| $64.3K | ﹤0.01% |
10,045
-365
| -4% | -$2.75K |
|
12029
CALL
Genasys
GNSS
$70.1M
| $63.8K | ﹤0.01% |
36,900
-1,200
| -3% | -$2.21K |
|
|
QVCGA
12030
DELISTED
QVC Group Inc Series A
QVCGA
| $63.8K | ﹤0.01% |
23,192
+22,662
| +4,276% | +$130K |
|
12031
PUT
Arbe Robotics
ARBE
$85.3M
| $63.7K | ﹤0.01% |
35,800
-78,600
| -69% | -$112K |
|
12032
Alpha Teknova
TKNO
$388M
| $63.6K | ﹤0.01% |
12,960
-163,420
| -93% | -$962K |
|
12033
CALL
Outdoor Holding Co
POWW
$252M
| $63.6K | ﹤0.01% |
49,700
+21,200
| +74% | +$33.6K |
|
|
FOLD
12034
CALL
DELISTED
Amicus Therapeutics
FOLD
| $63.6K | ﹤0.01% |
11,100
-8,600
| -44% | -$55.5K |
|
12035
PUT
Aldeyra Therapeutics
ALDX
$94.1M
| $63.6K | ﹤0.01% |
16,600
-21,400
| -56% | -$55.3K |
|
|
IHD
12036
Voya Emerging Markets High Income Dividend Equity Fund
IHD
$135M
| $63.4K | ﹤0.01% |
+10,680
| New | +$57.8K |
|
|
MASK
12037
3 E Network Technology Group
MASK
$4.5M
| $63.3K | ﹤0.01% |
1,146
+698
| +156% | +$58.5K |
|
12038
374Water
SCWO
$45.5M
| $63.1K | ﹤0.01% |
19,458
+11,453
| +143% | +$38.5K |
|
|
NB
12039
PUT
NioCorp Developments
NB
$630M
| $62.7K | ﹤0.01% |
26,900
+15,500
| +136% | +$38.7K |
|
12040
CALL
Genelux
GNLX
$124M
| $62.6K | ﹤0.01% |
+21,800
| New | +$57.6K |
|
12041
PUT
Evolution Petroleum
EPM
$123M
| $62.5K | ﹤0.01% |
+13,300
| New | +$60.3K |
|
|
GAU
12042
Galiano Gold
GAU
$620M
| $62.5K | ﹤0.01% |
49,215
-5,496
| -10% | -$7.47K |
|
12043
CALL
Avita Medical
RCEL
$328M
| $62.4K | ﹤0.01% |
+11,800
| New | +$85.8K |
|
12044
Harvard Bioscience
HBIO
$34.8M
| $62.3K | ﹤0.01% |
14,046
+7,765
| +124% | +$32.4K |
|
|
MVO
12045
PUT
DELISTED
MV Oil Trust
MVO
| $62.2K | ﹤0.01% |
+10,800
| New | +$62.6K |
|
12046
CALL
Lineage Cell Therapeutics
LCTX
$283M
| $62.2K | ﹤0.01% |
+68,300
| New | +$40.5K |
|
12047
PUT
Gerdau
GGB
$8.75B
| $61.6K | ﹤0.01% |
21,100
-14,900
| -41% | -$40.8K |
|
12048
CALL
Sensus Healthcare
SRTS
$54.2M
| $60.7K | ﹤0.01% |
12,800
-3,800
| -23% | -$17.8K |
|
12049
Cocrystal Pharma
COCP
$21.6M
| $60.5K | ﹤0.01% |
40,619
+6,936
| +21% | +$10.3K |
|
|
BULLZ
12050
DELISTED
Webull Corporation Incentive Warrant
BULLZ
| $60.3K | ﹤0.01% |
+32,254
| New | +$77K |
|
Similar funds
Jeff Yass's Q2 2025 Portfolio in Review
As of Q2 2025, Jeff Yass held 14,080 positions worth $720B, up 23% from $586B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass deployed $32.3B of net new capital in Q2 2025, opening 1,720 new positions and adding to 5,716 existing holdings. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.6% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $5.24B trimmed.
- Jeff Yass's largest Q2 2025 buy was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
- Jeff Yass added most to Apple in Q2 2025, an estimated $680M increase.
- Jeff Yass's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.24B.
- Jeff Yass fully exited Vanguard Intermediate-Term Bond ETF in Q2 2025, selling an estimated $61.8M.
- Jeff Yass's ten largest holdings make up 26% of its $720B portfolio in Q2 2025.
- Jeff Yass opened 1,720 new positions and closed 1,538 in Q2 2025.
- Jeff Yass's portfolio value rose 23% quarter-over-quarter to $720B.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.